A Randomized Trial to Evaluate the Sustained Efficacy of a Mucus Clearance Device in Ambulatory Patients with Chronic Obstructive Pulmonary Disease
OBJECTIVE: To determine whether a mucus clearance device (MCD) (Flutter; Axcan Scandipharm, USA) could consistently improve the bronchodilator response and exercise performance in patients with chronic obstructive pulmonary disease (COPD) when used in an ambulatory setting over a one-week period.
Main Authors: | Norman Wolkove, Marc A Baltzan, Hany Kamel, Michael Rotaple |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2004-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2004/828591 |
Similar Items
-
Pulmonary Rehabilitation Improves Functional Capacity in Patients 80 Years of Age or Older
by: Marcel A Baltzan, et al.
Published: (2004-01-01) -
Amiodarone Pulmonary Toxicity
by: Norman Wolkove, et al.
Published: (2009-01-01) -
Long-Term Compliance with Continuous Positive Airway Pressure in Patients with Obstructive Sleep Apnea
by: Norman Wolkove, et al.
Published: (2008-01-01) -
Examination of Pulse Oximetry Tracings to Detect Obstructive Sleep Apnea in Patients with Advanced Chronic Obstructive Pulmonary Disease
by: Adrienne S Scott, et al.
Published: (2014-01-01) -
Success in Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease
by: Adrienne S Scott, et al.
Published: (2010-01-01)